Cargando…

Altered Microbial Composition of Drug-Sensitive and Drug-Resistant TB Patients Compared with Healthy Volunteers

Mycobacterium tuberculosis infection has three discernible outcomes: active tuberculosis, latent tuberculosis, or clearance of the bacterium. The outcome of the infection depends on the interaction of the bacterium, the immune system, and the microbiome of the host. The current study uses 16S rRNA s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valdez-Palomares, Fernanda, Muñoz Torrico, Marcela, Palacios-González, Berenice, Soberón, Xavier, Silva-Herzog, Eugenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398572/ https://www.ncbi.nlm.nih.gov/pubmed/34442841 http://dx.doi.org/10.3390/microorganisms9081762

Ejemplares similares

Drug-Drug Interaction Analysis of Pyronaridine/Artesunate and Ritonavir in Healthy Volunteers
por: Morris, Carrie A., et al.
Publicado: (2012)

Drug‐Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers
por: Bashir, Babar, et al.
Publicado: (2018)

Reviewing the role of healthy volunteer studies in drug development
por: Karakunnel, Joyson J., et al.
Publicado: (2018)

Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers
por: Lesko, Lawrence J., et al.
Publicado: (2017)

Evaluation of drug interactions of saxagliptin with sildenafil in healthy volunteers
por: Mansour, Rania Y., et al.
Publicado: (2022)

Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers
por: Booij, L, et al.
Publicado: (2016)

Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers
por: Ribeiro, Isabela, et al.
Publicado: (2021)

Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteers
por: Topletz-Erickson, Ariel, et al.
Publicado: (2022)

Rapid Identification of Drug Resistance and Phylogeny in M. tuberculosis, Directly from Sputum Samples
por: Barbosa-Amezcua, Martín, et al.
Publicado: (2022)

Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2020)

Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteers
por: Kuchewar, Vaishali V., et al.
Publicado: (2014)

Healthy Volunteer Studies in the Development of Anticancer Drugs with Genotoxic Findings
por: Omes-Smit, Grace, et al.
Publicado: (2021)

Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers
por: Lee, Hae Won, et al.
Publicado: (2022)

Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers
por: Dutreix, Catherine, et al.
Publicado: (2013)

Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders
por: Johansson, Susanne, et al.
Publicado: (2016)

Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
por: Kim, Dasohm, et al.
Publicado: (2023)

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
por: Kang, Woo Youl, et al.
Publicado: (2020)

Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development
por: Ahmed, Mariam A., et al.
Publicado: (2019)

Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers
por: Park, Jungsin, et al.
Publicado: (2017)

Healthy volunteers in first‐in‐human oncology drug development for small molecules
por: de las Heras, Begoña, et al.
Publicado: (2021)

Clinical standards for drug-susceptible pulmonary TB
por: Akkerman, O. W., et al.
Publicado: (2022)

Clinical standards for the dosing and management of TB drugs
por: Alffenaar, J. W. C., et al.
Publicado: (2022)

Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis
por: Stott, K E, et al.
Publicado: (2018)

Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time
por: Téllez-Navarrete, Norma A., et al.
Publicado: (2021)

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers
por: Anderson, Matt S., et al.
Publicado: (2017)

Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
por: Lee, Jieon, et al.
Publicado: (2014)

Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo‐controlled drug–drug interaction study
por: Spyker, Daniel A., et al.
Publicado: (2015)

Semimechanistic Population Pharmacokinetic Model to Predict the Drug–Drug Interaction Between S‐ketamine and Ticlopidine in Healthy Human Volunteers
por: Ashraf, Muhammad W., et al.
Publicado: (2018)

Concomitant Intake of Coca‐Cola to Manage the Drug–Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy Volunteers
por: van Seyen, Minou, et al.
Publicado: (2019)

Napabucasin Drug‐Drug Interaction Potential, Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers
por: Dai, Xiaoshu, et al.
Publicado: (2021)

Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
por: Raizada, Neeraj, et al.
Publicado: (2014)

Prediction of pain sensitivity in healthy volunteers
por: Ravn, Pernille, et al.
Publicado: (2012)

Phase I clinical trials of anticancer drugs in healthy volunteers: Need for critical consideration
por: Gupta, Pooja, et al.
Publicado: (2012)

Quantitative prediction and clinical evaluation of an unexplored herb–drug interaction mechanism in healthy volunteers
por: Gufford, BT, et al.
Publicado: (2015)

Confronting TB/HIV in the era of increasing anti-TB drug resistance
por: Chakaya, Jeremiah, et al.
Publicado: (2008)

Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein‐Mediated Drug‐Drug Interactions in Healthy Volunteers
por: Miyake, Takeshi, et al.
Publicado: (2020)

Objective markers of drug effects on brain function from recordings of scalp potential in healthy volunteers
por: Boeijinga, Peter H.
Publicado: (2002)

Clinical Pharmacokinetic Drug Interaction Potential of MenoAct851 in Adult, Female Healthy Volunteers
por: Thangavel Mahalingam, Vijayakumar, et al.
Publicado: (2020)

Atripla(R)/anti-TB combination in TB/HIV patients. Drug in focus
por: Semvua, Hadija H, et al.
Publicado: (2011)

Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB
por: Bishai, Jason D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8ntsu0jhrsq3pfaarknpduoekr